Clinical Trial Update: Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of lenalidomide, dexamethasone, and cyclophosphamide in amyloidosis (AL) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloidosis

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: University of Athens | Conditions: Amyloidosis | Phase 1, Phase 2 | Status: COMPLETED